In a year-long phase II trial, Ambroxol, a widely used cough medicine in Europe, showed target engagement in patients with ...

Ambroxol is commonly used as an expectorant in cough syrup, helping thin out mucus so people with respiratory illnesses can ...

Treatment with ambroxol for symptoms of Parkinson’s disease dementia was safe, but its efficacy was undetermined in a small ...

Looking a treatment for symptoms of decline in thinking and reasoning skills? Recent study approves common cough syrup to ...

A safe and affordable treatment to slow the advancement of Parkinson's dementia has emerged – in the form of a commonly available cough syrup that's already being studied for its positive effect on ...

In a small clinical trial in Canada, a medicine commonly found in European cough syrups has shown early signs it might do ...

Ambroxol increased enzyme levels in Parkinson’s dementia patients, but showed no cognitive benefit in a year-long trial.

Ambroxol, a cough medication, may help stabilize the neuropsychiatric symptoms of Parkinson's disease dementia, a new study ...

Ambroxol, long used for coughs in Europe, stabilized symptoms and brain-damage markers in Parkinson’s dementia patients over 12 months, whereas placebo patients worsened. Those with high-risk ...

“Ambroxol was safe, well-tolerated, and demonstrated target engagement,” scientists wrote, however adding that the drug’s clinical effect on cognition was “not confirmed” in the study.

A clinical trial is beginning in the UK, testing whether a common cough medicine can be used to treat Parkinson's. Early studies indicate the 50-year-old drug can cross into the brain and help ...